{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T20:05:19Z","timestamp":1780344319408,"version":"3.54.1"},"publisher-location":"New York, NY","reference-count":37,"publisher":"Springer US","isbn-type":[{"value":"9781071631744","type":"print"},{"value":"9781071631751","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-3175-1_29","type":"book-chapter","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T07:02:13Z","timestamp":1684479733000},"page":"441-461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Whole Blood Procoagulant Platelet Flow Cytometry Protocol for Heparin-Induced Thrombocytopenia (HIT) and Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Testing"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3851-9364","authenticated-orcid":false,"given":"Christine S. M.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8621-6328","authenticated-orcid":false,"given":"Matthew C.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5119-7470","authenticated-orcid":false,"given":"Vivien M.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,20]]},"reference":[{"issue":"6","key":"29_CR1","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.06-2109","volume":"131","author":"MA Smythe","year":"2007","unstructured":"Smythe MA, Koerber JM, Mattson JC (2007) The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospital. Chest 131(6):1644\u20131649. https:\/\/doi.org\/10.1378\/chest.06-2109","journal-title":"Chest"},{"issue":"8","key":"29_CR2","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","volume":"106","author":"N Martel","year":"2005","unstructured":"Martel N, Lee J, Wells PS (2005) Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood 106(8):2710\u20132715. https:\/\/doi.org\/10.1182\/blood-2005-04-1546","journal-title":"Blood"},{"issue":"5","key":"29_CR3","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood.V96.5.1703","volume":"96","author":"TE Warkentin","year":"2000","unstructured":"Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG (2000) Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 96(5):1703\u20131708","journal-title":"Blood"},{"issue":"4","key":"29_CR4","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1046\/j.1365-2141.2002.03687.x","volume":"118","author":"E Lindhoff-Last","year":"2002","unstructured":"Lindhoff-Last E, Nakov R, Misselwitz F, Breddin HK, Bauersachs R (2002) Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin. Br J Haematol 118(4):1137\u20131142. https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03687.x","journal-title":"Br J Haematol"},{"issue":"1","key":"29_CR5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1160\/TH04-12-0825","volume":"94","author":"A Greinacher","year":"2005","unstructured":"Greinacher A, Farner B, Kroll H, Kohlmann T, Warkentin TE, Eichler P (2005) Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients. Thromb Haemost 94(1):132\u2013135. https:\/\/doi.org\/10.1160\/TH04-12-0825","journal-title":"Thromb Haemost"},{"issue":"1","key":"29_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-2141.1982.tb03863.x","volume":"52","author":"JC Giddings","year":"1982","unstructured":"Giddings JC, Brookes LR, Piovella F, Bloom AL (1982) Immunohistological comparison of platelet factor 4 (PF4), fibronectin (Fn) and factor VIII related antigen (VIIIR:Ag) in human platelet granules. Br J Haematol 52(1):79\u201388. https:\/\/doi.org\/10.1111\/j.1365-2141.1982.tb03863.x","journal-title":"Br J Haematol"},{"issue":"1","key":"29_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1055\/s-0038-1656329","volume":"68","author":"J Amiral","year":"1992","unstructured":"Amiral J, Bridey F, Dreyfus M, Vissoc AM, Fressinaud E, Wolf M, Meyer D (1992) Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 68(1):95\u201396","journal-title":"Thromb Haemost"},{"issue":"11","key":"29_CR8","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1182\/blood.V83.11.3232.3232","volume":"83","author":"JG Kelton","year":"1994","unstructured":"Kelton JG, Smith JW, Warkentin TE, Hayward CP, Denomme GA, Horsewood P (1994) Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 83(11):3232\u20133239","journal-title":"Blood"},{"issue":"3","key":"29_CR9","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1182\/blood.V72.3.925.bloodjournal723925","volume":"72","author":"JG Kelton","year":"1988","unstructured":"Kelton JG, Sheridan D, Santos A, Smith J, Steeves K, Smith C, Brown C, Murphy WG (1988) Heparin-induced thrombocytopenia: laboratory studies. Blood 72(3):925\u2013930","journal-title":"Blood"},{"issue":"22","key":"29_CR10","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","volume":"384","author":"A Greinacher","year":"2021","unstructured":"Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S (2021) Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med 384(22):2092\u20132101. https:\/\/doi.org\/10.1056\/NEJMoa2104840","journal-title":"N Engl J Med"},{"issue":"18","key":"29_CR11","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","volume":"385","author":"S Pavord","year":"2021","unstructured":"Pavord S, Scully M, Hunt BJ, Lester W, Bagot C, Craven B, Rampotas A, Ambler G, Makris M (2021) Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. N Engl J Med 385(18):1680\u20131689. https:\/\/doi.org\/10.1056\/NEJMoa2109908","journal-title":"N Engl J Med"},{"issue":"22","key":"29_CR12","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","volume":"384","author":"NH Schultz","year":"2021","unstructured":"Schultz NH, Sorvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, Wiedmann M, Aamodt AH, Skattor TH, Tjonnfjord GE, Holme PA (2021) Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med 384(22):2124\u20132130. https:\/\/doi.org\/10.1056\/NEJMoa2104882","journal-title":"N Engl J Med"},{"issue":"20","key":"29_CR13","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1056\/NEJMc2105869","volume":"384","author":"KL Muir","year":"2021","unstructured":"Muir KL, Kallam A, Koepsell SA, Gundabolu K (2021) Thrombotic thrombocytopenia after Ad26.COV2.S vaccination. N Engl J Med 384(20):1964\u20131965. https:\/\/doi.org\/10.1056\/NEJMc2105869","journal-title":"N Engl J Med"},{"issue":"24","key":"29_CR14","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1001\/jama.2021.7517","volume":"325","author":"I See","year":"2021","unstructured":"See I, Su JR, Lale A, Woo EJ, Guh AY, Shimabukuro TT, Streiff MB, Rao AK, Wheeler AP, Beavers SF, Durbin AP, Edwards K, Miller E, Harrington TA, Mba-Jonas A, Nair N, Nguyen DT, Talaat KR, Urrutia VC, Walker SC, Creech CB, Clark TA, DeStefano F, Broder KR (2021) US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, march 2 to April 21, 2021. JAMA 325(24):2448\u20132456. https:\/\/doi.org\/10.1001\/jama.2021.7517","journal-title":"JAMA"},{"issue":"3","key":"29_CR15","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/jth.15604","volume":"20","author":"S Johansen","year":"2022","unstructured":"Johansen S, Laegreid IJ, Ernstsen SL, Azrakhsh NA, Kittang AO, Lindas R, Gjertsen BT, Vetti N, Mortberg TV, Sorvoll IH, Holme PA, Ahlen MT, Reikvam H (2022) Thrombosis and thrombocytopenia after HPV vaccination. J Thromb Haemost 20(3):700\u2013704. https:\/\/doi.org\/10.1111\/jth.15604","journal-title":"J Thromb Haemost"},{"key":"29_CR16","unstructured":"COVID-19 vaccine safety report - 06-10-2022. (2022) Therapeutic Goods Administration, Department of Health and Aged Care, Australian Government. https:\/\/www.tga.gov.au\/news\/covid-19-vaccine-safety-reports\/covid-19-vaccine-safety-report-06-10-2022#vaxzevria-astrazeneca-vaccine. Accessed 7 Oct 2022"},{"issue":"17","key":"29_CR17","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1182\/blood.2021015329","volume":"139","author":"K Krzywicka","year":"2022","unstructured":"Krzywicka K, van de Munckhof A, Zimmermann J, Bode FJ, Frisullo G, Karapanayiotides T, Potzsch B, Sanchez van Kammen M, Heldner MR, Arnold M, Kremer Hovinga JA, Ferro JM, Aguiar de Sousa D, Coutinho JM (2022) Cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia after a second ChAdOx1 nCoV-19 dose. Blood 139(17):2720\u20132724. https:\/\/doi.org\/10.1182\/blood.2021015329","journal-title":"Blood"},{"issue":"10300","key":"29_CR18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0140-6736(21)01693-7","volume":"398","author":"P Bhuyan","year":"2021","unstructured":"Bhuyan P, Medin J, da Silva HG, Yadavalli M, Shankar NK, Mullerova H, Arnold M, Nord M (2021) Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis. Lancet 398(10300):577\u2013578. https:\/\/doi.org\/10.1016\/S0140-6736(21)01693-7","journal-title":"Lancet"},{"issue":"23","key":"29_CR19","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1056\/NEJMe2106315","volume":"384","author":"DB Cines","year":"2021","unstructured":"Cines DB, Bussel JB (2021) SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia. N Engl J Med 384(23):2254\u20132256. https:\/\/doi.org\/10.1056\/NEJMe2106315","journal-title":"N Engl J Med"},{"issue":"23","key":"29_CR20","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","volume":"384","author":"M Scully","year":"2021","unstructured":"Scully M, Singh D, Lown R, Poles A, Solomon T, Levi M, Goldblatt D, Kotoucek P, Thomas W, Lester W (2021) Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. N Engl J Med 384(23):2202\u20132211. https:\/\/doi.org\/10.1056\/NEJMoa2105385","journal-title":"N Engl J Med"},{"issue":"8","key":"29_CR21","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1111\/jth.15362","volume":"19","author":"S Platton","year":"2021","unstructured":"Platton S, Bartlett A, MacCallum P, Makris M, McDonald V, Singh D, Scully M, Pavord S (2021) Evaluation of laboratory assays for anti-platelet factor 4 antibodies after ChAdOx1 nCOV-19 vaccination. J Thromb Haemost 19(8):2007\u20132013. https:\/\/doi.org\/10.1111\/jth.15362","journal-title":"J Thromb Haemost"},{"issue":"1","key":"29_CR22","doi-asserted-by":"publisher","first-page":"7961","DOI":"10.1038\/s41598-022-11623-9","volume":"12","author":"TS Cohen","year":"2022","unstructured":"Cohen TS, Kelly EJ, Nylander S, Bansal H, Jepson BM, Bhuyan P, Sobieszczyk ME, Falsey AR (2022) Serum levels of anti-PF4 IgG after AZD1222 (ChAdOx1 nCoV-19) vaccination. Sci Rep 12(1):7961. https:\/\/doi.org\/10.1038\/s41598-022-11623-9","journal-title":"Sci Rep"},{"key":"29_CR23","doi-asserted-by":"publisher","unstructured":"Terpos E, Politou M, Ntanasis-Stathopoulos I, Karalis V, Merkouri E, Fotiou D, Gavriatopoulou M, Malandrakis P, Kastritis E, Trougakos IP, Dimopoulos MA (2021) High prevalence of anti-PF4 antibodies following ChAdOx1 nCov-19 (AZD1222) vaccination even in the absence of thrombotic events. Vaccines (Basel) 9(7). https:\/\/doi.org\/10.3390\/vaccines9070712","DOI":"10.3390\/vaccines9070712"},{"key":"29_CR24","doi-asserted-by":"publisher","unstructured":"Favaloro EJ, Clifford J, Leitinger E, Parker M, Sung P, Chunilal S, Tran H, Kershaw G, Fu S, Passam F, Ahuja M, Ho SJ, Duncan E, Yacoub O, Tan CW, Kaminskis L, Modica N, Pepperell D, Ballard L, Clarke L, Lee CSM, Gardiner EE, Young-Ill Choi P, Tohidi-Esfahani I, Bird R, Brighton T, Chen VM (2022) Assessment of immunological anti-platelet factor 4 antibodies for vaccine-induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: a multicenter study comprising 1284 patients. J Thromb Haemost 20(12):2896\u20132908. https:\/\/doi.org\/10.1111\/jth.15881","DOI":"10.1111\/jth.15881"},{"issue":"7","key":"29_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/ajh.24025","volume":"90","author":"I Nazi","year":"2015","unstructured":"Nazi I, Arnold DM, Moore JC, Smith JW, Ivetic N, Horsewood P, Warkentin TE, Kelton JG (2015) Pitfalls in the diagnosis of heparin-induced thrombocytopenia: a 6-year experience from a reference laboratory. Am J Hematol 90(7):629\u2013633. https:\/\/doi.org\/10.1002\/ajh.24025","journal-title":"Am J Hematol"},{"issue":"22","key":"29_CR26","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","volume":"2","author":"A Cuker","year":"2018","unstructured":"Cuker A, Arepally GM, Chong BH, Cines DB, Greinacher A, Gruel Y, Linkins LA, Rodner SB, Selleng S, Warkentin TE, Wex A, Mustafa RA, Morgan RL, Santesso N (2018) American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv 2(22):3360\u20133392. https:\/\/doi.org\/10.1182\/bloodadvances.2018024489","journal-title":"Blood Adv"},{"key":"29_CR27","unstructured":"THANZ Advisory Statement for Haematologists on Suspected Vaccine Induced Immune Thrombotic Thrombocytopenia (VITT) (Updated 19 August 2021). (2021) Thrombosis & Haemostasis Society of Australia and New Zealand. https:\/\/www.thanz.org.au\/documents\/item\/591. Accessed 26 May 2022"},{"key":"29_CR28","unstructured":"ISTH Interim Guidance for the Diagnosis and Treatment on Vaccine Induced Immune Thrombotic Thrombocytopenia (Updated 20 April, 2021). (2021) International Society on Thrombosis and Haemostasis. https:\/\/cdn.ymaws.com\/www.isth.org\/resource\/resmgr\/ISTH_VITT_Guidance_2.pdf. Accessed 16 Sept 2021"},{"key":"29_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/978-1-4939-9187-7_20","volume":"1967","author":"CW Tan","year":"2019","unstructured":"Tan CW, Bourcy M, Pasalic L, Chen VM (2019) Flow cytometry assessment of procoagulant platelets using a dithiol-reactive probe. Methods Mol Biol 1967:305\u2013321. https:\/\/doi.org\/10.1007\/978-1-4939-9187-7_20","journal-title":"Methods Mol Biol"},{"issue":"6","key":"29_CR30","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/jth.14008","volume":"16","author":"L Pasalic","year":"2018","unstructured":"Pasalic L, Wing-Lun E, Lau JK, Campbell H, Pennings GJ, Lau E, Connor D, Liang HP, Muller D, Kritharides L, Hogg PJ, Chen VM (2018) Novel assay demonstrates that coronary artery disease patients have heightened procoagulant platelet response. J Thromb Haemost 16(6):1198\u20131210. https:\/\/doi.org\/10.1111\/jth.14008","journal-title":"J Thromb Haemost"},{"issue":"4","key":"29_CR31","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1055\/s-0034-1544002","volume":"41","author":"VM Hua","year":"2015","unstructured":"Hua VM, Chen VM (2015) Procoagulant platelets and the pathways leading to cell death. Semin Thromb Hemost 41(4):405\u2013412. https:\/\/doi.org\/10.1055\/s-0034-1544002","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"29_CR32","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/jth.15650","volume":"20","author":"CSM Lee","year":"2022","unstructured":"Lee CSM, Selvadurai MV, Pasalic L, Yeung J, Konda M, Kershaw GW, Favaloro EJ, Chen VM (2022) Measurement of procoagulant platelets provides mechanistic insight and diagnostic potential in heparin-induced thrombocytopenia. J Thromb Haemost 20(4):975\u2013988. https:\/\/doi.org\/10.1111\/jth.15650","journal-title":"J Thromb Haemost"},{"issue":"11","key":"29_CR33","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1182\/bloodadvances.2021006698","volume":"6","author":"CSM Lee","year":"2022","unstructured":"Lee CSM, Liang HPH, Connor DE, Dey A, Tohidi-Esfahani I, Campbell H, Whittaker S, Capraro D, Favaloro EJ, Donikian D, Kondo M, Hicks SM, Choi PY, Gardiner EE, Clarke LJ, Tran H, Passam FH, Brighton TA, Chen VM (2022) A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia. Blood Adv 6(11):3494\u20133506. https:\/\/doi.org\/10.1182\/bloodadvances.2021006698","journal-title":"Blood Adv"},{"key":"29_CR34","unstructured":"Adcock DM, Hoefner DM, Kottke-Marchant K, Marlar RA, Szamosi DI, Warunek DJ (2008) Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays, 5th edition. 28"},{"issue":"11","key":"29_CR35","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1111\/jphp.12143","volume":"65","author":"LJ Dick","year":"2013","unstructured":"Dick LJ, Gray A, Ram A, Hume A, Parris C, Hogg PJ, Elliott MA, Ford SJ, Halbert GW (2013) Elimination of the antimicrobial action of the organoarsenical cancer therapeutic, 4-(N-(S-glutathionylacetyl)amino) phenylarsonous acid, before finished product sterility testing. J Pharm Pharmacol 65(11):1664\u20131669. https:\/\/doi.org\/10.1111\/jphp.12143","journal-title":"J Pharm Pharmacol"},{"issue":"12","key":"29_CR36","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1111\/jth.13516","volume":"14","author":"MC Morel-Kopp","year":"2016","unstructured":"Morel-Kopp MC, Mullier F, Gkalea V, Bakchoul T, Minet V, Elalamy I, Ward CM, subcommittee on platelet i (2016) Heparin-induced multi-electrode aggregometry method for heparin-induced thrombocytopenia testing: communication from the SSC of the ISTH. J Thromb Haemost 14(12):2548\u20132552. https:\/\/doi.org\/10.1111\/jth.13516","journal-title":"J Thromb Haemost"},{"key":"29_CR37","volume-title":"Procoagulant platelets in health and disease","author":"L Pasalic","year":"2016","unstructured":"Pasalic L (2016) Procoagulant platelets in health and disease. University of New South Wales, Sydney, Australia"}],"container-title":["Methods in Molecular Biology","Hemostasis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3175-1_29","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T07:06:30Z","timestamp":1684479990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3175-1_29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9781071631744","9781071631751"],"references-count":37,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3175-1_29","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"20 May 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}